UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

---

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 1, 2013

 

SYMMETRY MEDICAL INC.

(Exact name of Registrant as specified in its charter)

 

---

 

Delaware		001-32374		35-1996126
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

 

3724 N State Road 15, Warsaw, Indiana 46582

(Address of Principal executive offices, including Zip Code)

 

(574) 268-2252

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Item 2.02.  Results of Operations and Financial Condition

 

On August 1, 2013, Symmetry Medical Inc. (“Symmetry”) issued a press release entitled, “Symmetry Medical Reports Second Quarter 2013 Financial Results,” in which it announced its second fiscal quarter 2013 financial results.

 

A copy of this press release is being furnished as Exhibit 99.1.

 

Item 9.01.  Financial Statements and Exhibits

 

(d)

Exhibits

 

99.1	“Symmetry Medical Reports Second Quarter 2013 Financial Results,” Press Release issued by Symmetry Medical, Inc. dated August 1, 2013.

________________

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	Symmetry Medical Inc.
	/s/ Fred L. Hite
Date: August 1, 2013	Name:  Fred L. Hite
	Title:    Chief Financial Officer

 

 

EXHIBIT INDEX

  

Exhibit No.		Description
99.1		“Symmetry Medical Reports Second Quarter 2013 Financial Results,” Press Release issued by Symmetry Medical, Inc. dated August 1, 2013.